Automotive CCC

China Certification is an excellent partner for the CCC certification in the automotive sector. We are providing leading automotive suppliers and car manufacturers with quick and smart solutions for their CCC certification. We offer you our support for every project related to the Automotive CCC.

Lire la suite

CCC Made Easy

The China Compulsory Certification (CCC) is a mandatory certification for products exported to China.
We are experienced in the CCC certification process for all kinds of product categories. The CCC certification process will be simple and easy with China Certification Corporation as a professional partner by your side.

Lire la suite


Cosmetic products and medical devices need a CFDA registration before they can be sold in China. We offer the evaluation of CFDA classifications (Class I – III) for the medical devices, and guide you through the complete approval processes.

Lire la suite

Other Certifications

HAF604, Taiwan Certification, CRCC for Railway Products, SRRC Type Approval, NAL (Network Access License), AQSIQ registration, Voluntary CQC Mark Certification, CCCF for Fire Products: We support you in all types of certifications for the Chinese market.


China Certification provides a range of specialized consulting services, especially for car manufacturers and large industrial companies. With the consulting packages the certifications as well as internal procedures related to international product certifications can be streamlined.


China Certification Corporation offers customized CCC training to fit your company needs. Our trainer will come to your location and provide the training, up to date information and pass on valuable tips from our many years of experience. Call us today to learn more!


Since 2005, MPR China Certification GmbH – China Certification Corporation has been supporting companies around the world in obtaining the required product certifications for the Chinese market. With a strong team located worldwide, we can offer you the best solution for your enquiries.

Lire la suite

Ebola vaccine wins approval from China Food and Drug Administration

According to the official Chinese news agency Xinhua, medical company, Tianjin CanSino Biotechnology is investing around 2 billion yuan to build a major medical facility in Tianjin to produce a revolutionary Ebola vaccine.

Notably, this makes China the third country, along with the USA and Russia, with vaccines ready to combat Ebola.

The vaccine, which was developed in conjunction with the Chinese military and was approved by the China Food and Drug Administration (CFDA), who are responsible for food safety, drugs, medical devices and cosmetics, has been developed as a response to the West African Ebola Epidemic that tragically led to the death of around 11,000 people.

Ebola virus

Tianjin CanSino Biotechnology started trials last year and intend on having the new facility up and running by 2018 and hope it will challenge current global Ebola vaccination leaders Merck and NewLink Genetics. Though a production date has yet to be set.

Currently Merck and NewLink Genetics vaccine comes in liquid form, Tianjin CanSino Biotechnology will be available in powder form, which the firm claim will be a far better solution because it can be more easily transported and used in harsher tropical climates.

For more information on how CFDA Certification may affect your company, or for more information about the CFDA certification in general, the process and the associated costs, please visit our website and our News Section where you will find current updates twice a week.

Please do not hesitate to contact us for further details and consultation. You can contact us via e-mail, or call us (UK: +44 2071931135, Rest of Europe: +49 69 2713769150, US: +1 773 654-2673).

Julian Busch

Informazioni sull’autore: Julian Busch è il fondatore e direttoe della MPR International GmbH

Editore: MPR International GmbH

Tel.: +49 69 271 37 69 150

Third party cookies & scripts

This website uses third-party cookies and scripts (e.g., embedded videos). For optimal performance, it is recommended that you agree to third party cookies and scripts. For more information, see privacy policy and the imprint.Do you agree to the use of cookies & scripts?


Click here if you do not want to use cookies & scripts.

You can change your settings at any time under Privacy